AMDF / RPB Catalyst Award
The AMDF / RPB Catalyst Award funds pioneering research to advance understanding and treatment of age-related macular degeneration, supported by the American Macular Degeneration Foundation.
Funder: American Macular Degeneration Foundation
Due Dates (Anticipated): March 2027 (Full application deadline, projected)
Funding Amounts: Co-funded; amount varies by project scope and duration, leveraging resources from AMDF and RPB
Summary: Supports high-risk, high-gain research to advance understanding or treatment of age-related macular degeneration (AMD) through a co-funding partnership.
Description
The AMDF / RPB Catalyst Award is a partnership grant from the American Macular Degeneration Foundation (AMDF) and Research to Prevent Blindness, Inc. (RPB), designed to support bold, innovative research projects targeting age-related macular degeneration (AMD). This award specifically seeks proposals for high-risk, high-reward studies that either improve the understanding of AMD mechanisms or develop novel treatments for dry or wet forms of the disease. The collaboration leverages the resources of both organizations, aiming to maximize the impact and reach of funded research.
